Investors
Sign up for our Investors Newsletter and get early access to our latest product development and scientific research.
Some of our proud achievements:
01
US & EU Patent Approved 2018
02
Customer data integrity & security
03
Pioneers in high-throughput glycan analyse
Our numbers speak for themselves
€15M +
EU research funding
200 +
Scientific publications in leading journals
200k +
People sample baseline from 30 different countries
40 +
Scientists available to us from Genos
Sign up for our Investors Newsletter and get early access to our latest product development and scientific research.